Breaks Categories: News

WednesdayAug 01, 2018 10:01 am

CannabisNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Inks Exclusive National Agreement with Natural Specialty Sales

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) this morning announced that it has signed an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is well known in the natural/specialty market with a retail channel across America, providing Phivida access to over 2,400 retail locations in a $4.1 billion market. The national network includes major retailers including Whole Foods Market, Sprouts Farmers Market, and National Coop Grocers. The company’s OKI brand of premium CBD products, anticipated to launch in Q3 2018, will be the exclusive CBD-infused beverage brand and health supplements products represented by NSS. "There is no…

Continue Reading

WednesdayAug 01, 2018 9:30 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Encouraging Bioavailability Results from TurboCBD™ Study

Drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning reported noteworthy bioavailability results from its randomized, placebo-controlled, double-blind European human clinical study that evaluated TurboCBD™. TurboCBD™ is a proprietary, DehydraTECH™ powered, cannabidiol ("CBD") fortified hemp oil capsule developed by Lexaria. The study evaluated the degree and speed of CBD absorption into blood plasma and potential cardiovascular and cognitive performance enhancement in 12 healthy male volunteers. The study compared the 90 mg dose of Lexaria's TurboCBD™ to a 90 mg dose of a positive control formulation without Lexaria's DehydraTECH™ technology. Per the report, Lexaria's TurboCBD™ capsules continued to…

Continue Reading

TuesdayJul 31, 2018 1:33 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Posts Update on Scorpion Venom-Derived Peptide Program

PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) today issued an update regarding the second phase of its three phase, scorpion venom-derived peptide research and development program. The program consists of identifying, extracting and sequencing peptides and proteins isolated from Caribbean Blue Scorpion venom. The goal of the program is to empower PreveCeutical to produce Nature Identical™ peptide therapeutics to treat, regulate and prevent cancer progression. The company’s initial focus will target glioblastoma, a highly-aggressive form of brain cancer. PreveCeutical has started phase 2 of the program, comprised of re-designing the peptides to enhance their biostability while upholding their potency…

Continue Reading

TuesdayJul 31, 2018 11:06 am

CannabisNewsBreaks – Marijuana Company of America Inc. (MCOA) and Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) Issue Update on CBD Farming Project in Scio, Oregon

Marijuana Company of America (OTC: MCOA) and its joint venture (“JV”) partner Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) provided an update this morning on their CBD hemp farming project in Scio, Oregon. The 2018 hemp cultivation at the farm, operating under the name Covered Bridge Acres (“CBA”), is ongoing. Approximately 40,000 high CBD yielding hemp plants have been planted on the lower two fields of the farm, on approximately 33 acres. Six different high CBD yielding hemp cultivars were planted this year, half of which were planted as clones and the other half were grown from…

Continue Reading

TuesdayJul 31, 2018 10:28 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Enters Definitive Agreement to Acquire Canna Farms Ltd.

Globally licensed cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced its entrance into a definitive agreement to acquire 100% of the issued and outstanding share capital of Canna Farms Limited, a premium cannabis company in British Columbia. The acquisition enables the two complementary businesses to leverage their strengths prior to the opening of the Canadian adult-use market in the fall. The transaction value of approximately $133 million will be comprised of $22 million in cash and 92.5 million ABcann shares. The shares will be released from escrow in six month increments over a total of 30…

Continue Reading

TuesdayJul 31, 2018 9:55 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Definitive Agreement with Hill Street Beverage Company, Inc. (TSXV: BEER)

Drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP), together with Hill Street Beverage Company (TSXV: BEER), this morning announced that the companies have signed a definitive agreement to license Lexaria's DehydraTECH™ for five years on a semi-exclusive basis to produce a line of cannabis-infused alcohol-free beverages to be distributed in Canada following regulatory approval. The purchase price shall be partially paid to Lexaria in common shares in the capital of Hill Street totaling $56,250, which is equal to 419,982 common shares. The issuance of the shares is subject to regulatory approval. "Hill Street's award-winning and great-tasting wines and…

Continue Reading

MondayJul 30, 2018 10:40 am

CannabisNewsBreaks – The Flowr Corp. Discusses Company Activities in Interview with New Cannabis Ventures

The Flowr Corp. was the subject of a recent article by New Cannabis Ventures highlighting the company’s activities as it prepares to become publicly-listed. CEO Tom Flow and Chairman of the Board and Chief Strategist Steve Klein provided an exclusive interview with New Cannabis Ventures discussing its strategy to compete in the booming Canadian market. Per the article, the company is currently building its 84,000-square-foot flagship facility in Kelowna, British Columbia, which is expected to be complete by year-end with an annual production capacity of 12,000 to 15,000 kilos. The company is also designing other facilities, which will bring Flowr’s…

Continue Reading

FridayJul 27, 2018 9:39 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Introduces FIRESIDE Recreational Cannabis Brand

Globally licensed cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the introduction of FIRESIDE, its first recreational cannabis brand. Per the update, FIRESIDE has been tailored specifically for social cannabis users, based on extensive research and consumer insights. When the adult-use recreational cannabis market opens to Canadians on October 17, 2018, FIRESIDE products will be available in both dried whole-bud and pre-rolled formats. “Legalization will bring a wide variety of different consumers to cannabis, and many will want a high-quality product without having to be an expert at choosing between strains,” Sung Kang, chief marketing officer…

Continue Reading

ThursdayJul 26, 2018 9:50 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Names New Chief Information Officer

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTC: TGODF) this morning announced the appointment of Geoff Riggs as Chief Information Officer. Riggs will help guide the company’s direction on information technology, e-commerce and artificial intelligence strategies to support TGOD’s domestic and global expansion. By utilizing big-data mining and predictive analytics, TGOD intends to optimize all aspects of the company, including product sales forecasting, integrated greenhouse operations, consumer engagement and the development of intellectual property to create an artificial intelligence decision support system for the global cannabis industry. “All modern industries are data driven and the…

Continue Reading

TuesdayJul 24, 2018 11:08 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Launches Medicinal Cannabis Division

PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the launch of a medicinal cannabis division, advancing PreveCeutical’s vision of becoming a global preventive healthcare company. The cannabis division’s responsibilities include bringing various high-quality, medicinal cannabis-based products to market and managing the company's nasal delivery Sol-gel research program as well as any resulting formulations. The cannabis division’s products will include transdermal patches, topical creams, capsules and other methods of administering medicinal cannabis. "The opening of the cannabis division at this crucial moment is very exciting and continues to move the company in an important direction. With Canada's upcoming…

Continue Reading